Goel, K.K.; Hussain, A.; Altamimi, M.A.; Rajput, S.K.; Sharma, P.P.; Kharb, R.; Mahdi, W.A.; Imam, S.S.; Alshehri, S.; Alnemer, O.A.;
et al. Identification of Potential Antitubulin Agents with Anticancer Assets from a Series of Imidazo[1,2-a]quinoxaline Derivatives: In Silico and In Vitro Approaches. Molecules 2023, 28, 802.
https://doi.org/10.3390/molecules28020802
AMA Style
Goel KK, Hussain A, Altamimi MA, Rajput SK, Sharma PP, Kharb R, Mahdi WA, Imam SS, Alshehri S, Alnemer OA,
et al. Identification of Potential Antitubulin Agents with Anticancer Assets from a Series of Imidazo[1,2-a]quinoxaline Derivatives: In Silico and In Vitro Approaches. Molecules. 2023; 28(2):802.
https://doi.org/10.3390/molecules28020802
Chicago/Turabian Style
Goel, Kapil Kumar, Afzal Hussain, Mohammad A. Altamimi, Satyendra Kumar Rajput, Prince Prashant Sharma, Rajeev Kharb, Wael A. Mahdi, Syed Sarim Imam, Sultan Alshehri, Osamah Abdulrahman Alnemer,
and et al. 2023. "Identification of Potential Antitubulin Agents with Anticancer Assets from a Series of Imidazo[1,2-a]quinoxaline Derivatives: In Silico and In Vitro Approaches" Molecules 28, no. 2: 802.
https://doi.org/10.3390/molecules28020802
APA Style
Goel, K. K., Hussain, A., Altamimi, M. A., Rajput, S. K., Sharma, P. P., Kharb, R., Mahdi, W. A., Imam, S. S., Alshehri, S., Alnemer, O. A., & Chaudhary, A.
(2023). Identification of Potential Antitubulin Agents with Anticancer Assets from a Series of Imidazo[1,2-a]quinoxaline Derivatives: In Silico and In Vitro Approaches. Molecules, 28(2), 802.
https://doi.org/10.3390/molecules28020802
